25 related articles for article (PubMed ID: 38493729)
1. The Antiviral Potential of AdipoRon, an Adiponectin Receptor Agonist, Reveals the Ability of Zika Virus to Deregulate Adiponectin Receptor Expression.
El Safadi D; Lebeau G; Turpin J; Lefebvre d'Hellencourt C; Diotel N; Viranaicken W; Krejbich-Trotot P
Viruses; 2023 Dec; 16(1):. PubMed ID: 38257725
[TBL] [Abstract][Full Text] [Related]
2. Novel quinoline substituted autophagy inhibitors attenuate Zika virus replication in ocular cells.
Singh S; Ahmad F; Aruri H; Das S; Parajuli P; Gavande NS; Singh PK; Kumar A
Virus Res; 2024 Jun; 347():199419. PubMed ID: 38880335
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antiviral activity of new dermaseptin analogs against Zika virus.
Haddad H; Tangy F; Ouahchi I; Sahtout W; Ouni B; Zaïri A
Biochem Biophys Rep; 2024 Sep; 39():101747. PubMed ID: 38939125
[TBL] [Abstract][Full Text] [Related]
4. Identification of an N-phenylsulfonyl-2-(piperazin-1-yl)methyl-benzonitrile derivative as Zika virus entry inhibitor.
Quan Y; Zhou R; Yang B; Wang L; Wang Y; Ji Y; Li Y; Cen S
Bioorg Chem; 2023 Jan; 130():106265. PubMed ID: 36417826
[TBL] [Abstract][Full Text] [Related]
5. Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.
Baltina LA; Lai HC; Liu YC; Huang SH; Hour MJ; Baltina LA; Nugumanov TR; Borisevich SS; Khalilov LM; Petrova SF; Khursan SL; Lin CW
Bioorg Med Chem; 2021 Jul; 41():116204. PubMed ID: 34022526
[TBL] [Abstract][Full Text] [Related]
6. The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking
Riva L; Goellner S; Biering SB; Huang CT; Rubanov AN; Haselmann U; Warnes CM; De Jesus PD; Martin-Sancho L; Terskikh AV; Harris E; Pinkerton AB; Bartenschlager R; Chanda SK
J Virol; 2021 Oct; 95(22):e0099621. PubMed ID: 34468177
[TBL] [Abstract][Full Text] [Related]
7. Identification of Inhibitors of ZIKV Replication.
Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
Adcock RS; Chu YK; Golden JE; Chung DH
Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and antiviral activity of 1-aryl-4-arylmethylpiperazine derivatives as Zika virus inhibitors with broad antiviral spectrum.
Ji Y; Wang L; Zhou R; Yang X; Li S; Cen S; Li Y
Bioorg Med Chem; 2024 Apr; 103():117682. PubMed ID: 38493729
[TBL] [Abstract][Full Text] [Related]
10. Strategies for Zika drug discovery.
Zou J; Shi PY
Curr Opin Virol; 2019 Apr; 35():19-26. PubMed ID: 30852345
[TBL] [Abstract][Full Text] [Related]
11. Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options.
Koppolu V; Shantha Raju T
J Neurovirol; 2018 Jun; 24(3):255-272. PubMed ID: 29441490
[TBL] [Abstract][Full Text] [Related]
12. Secondary metabolites as potential drug candidates against Zika virus, an emerging looming human threat: Current landscape, molecular mechanism and challenges ahead.
Sadeer NB; El Kalamouni C; Khalid A; Abdalla AN; Zengin G; Khoa Bao LV; Mahomoodally MF
J Infect Public Health; 2023 May; 16(5):754-770. PubMed ID: 36958171
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
